ID   YPIX_CLOPF              Reviewed;         342 AA.
AC   P18020;
DT   01-NOV-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1990, sequence version 1.
DT   25-MAY-2022, entry version 60.
DE   RecName: Full=Uncharacterized 38.4 kDa protein;
DE   AltName: Full=ORF10;
OS   Clostridium perfringens.
OG   Plasmid pIP404.
OC   Bacteria; Firmicutes; Clostridia; Eubacteriales; Clostridiaceae;
OC   Clostridium.
OX   NCBI_TaxID=1502;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=CPN50;
RX   PubMed=2901768; DOI=10.1016/0147-619x(88)90052-2;
RA   Garnier T., Cole S.T.;
RT   "Complete nucleotide sequence and genetic organization of the
RT   bacteriocinogenic plasmid, pIP404, from Clostridium perfringens.";
RL   Plasmid 19:134-150(1988).
CC   -!- SIMILARITY: To C.perfringens CPE1502. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M32882; AAA98256.1; -; Genomic_DNA.
DR   PIR; JT0370; JT0370.
DR   RefSeq; NP_040458.1; NC_001388.1.
DR   RefSeq; WP_010889930.1; NZ_MDJF01000004.1.
DR   AlphaFoldDB; P18020; -.
DR   SMR; P18020; -.
DR   GO; GO:0008745; F:N-acetylmuramoyl-L-alanine amidase activity; IEA:InterPro.
DR   GO; GO:0009253; P:peptidoglycan catabolic process; IEA:InterPro.
DR   CDD; cd02696; MurNAc-LAA; 1.
DR   InterPro; IPR002508; MurNAc-LAA_cat.
DR   Pfam; PF01520; Amidase_3; 1.
DR   SMART; SM00646; Ami_3; 1.
PE   4: Predicted;
KW   Plasmid.
FT   CHAIN           1..342
FT                   /note="Uncharacterized 38.4 kDa protein"
FT                   /id="PRO_0000208254"
FT   DOMAIN          3..173
FT                   /note="MurNAc-LAA"
FT                   /evidence="ECO:0000255"
SQ   SEQUENCE   342 AA;  38364 MW;  BA9BBFCAEA8EB135 CRC64;
     MKIAIRGGHN FLAKGACGLI DETIEDRKVY KAVIKNLIEN NFEVLDVTPG DCDINTDLKL
     GVDKANNFNA DLFISIHFDK CYDKFDGPLG TGTWVCEKGG KAEIYAQNIV DTISEGTSLK
     NRGVKTNAKL YELNKTIMPA VIVEVCFCES KVDVDIYREK GSDLIGYLIA KGICKSVNKE
     ISSDLPQVNL ENTTNSQNNN LFKTNATAKV ALDPRDNPSN NYKDLGEIYE NERIKILAEV
     CDLKFFLPAT YWQDSLNKES SPIWVNSKQT VLNVDTNATV INVLTELDAR YTPSPDSNRM
     GYVKNQERLF VHKIENNYAL ATYLASEGYK TAWFTAEYIK LD